News

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...
Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...
The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...
The U.S. health secretary ordered an end to new mRNA development efforts just after UTMB published new research showing its ...
CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal has upheld the validity of Moderna’s EP’949 patent. This decision affirms the ...